课题基金 / 基金详情

Targeting novel BioNanofluids for prostate cancer therapy

Targeting novel BioNanofluids for prostate cancer therapy
针对前列腺癌治疗的新型生物纳米流体
批准号：
315093
负责人：
Trifiro Mark A
金额：
$10.8万
依托单位：
Lady Davis Institute for Medical Research (Mtl)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2014
资助国家：
加拿大
项目状态：
已结题
起止时间：
2014-09-01 至 2015-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=315093&lang=en
关键词：
Bionanofluid Imaging Pmsa Prostate Cancer Targeted Therapy Xenotransplant

项目摘要

项目成果

Trifiro Mark A的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Prostate cancer has become one of the most commonly diagnosed cancers in men. Adequate treatment of prostate cancer is still very challenging. Surgery and radiotherapy can result in complications such as impotence and incontinence. Hormonal therapy usuall
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Plasmonic PCR: Rapid Point-of-Care COVID-19 Diagnostic Platform.
Using a novel androgen receptor knock-in mouse model to investigate defects in circadian rhythm linked to the development Metabolic Syndrome.
Ultra-fast High Throughput Digital PCR Platform: Redefining Point-of-Care Diagnostics
Innovative Approaches to Functional Characterization of the Androgen Receptor in Prostate Cancer
国内基金
海外基金
非小细胞肺癌Biomarker的Imaging MS研究新方法
  • 批准号：
    30672394
  • 项目类别：
    面上项目
  • 资助金额：
    30.0万元
  • 批准年份：
    2006
  • 负责人：
    陆豪杰
  • 依托单位：
    复旦大学